Related Experiment Videos
Massive intraocular hemorrhage associated with anticoagulation and age-related macular degeneration
Insights
Patients on anticoagulant therapy with disciform macular degeneration face a risk of massive intraocular hemorrhage. This bleeding originates from new vessels in macular lesions, requiring coordinated care from ophthalmologists and internists.
Area of Science:
- Ophthalmology
- Vascular Biology
- Retinal Diseases
Background:
- Anticoagulant therapy is frequently prescribed for various medical conditions.
- Disciform macular degeneration is a known cause of visual impairment.
- Extrachoroidal neovascularization can occur in the context of macular degeneration.
Observation:
- Three cases of massive intraocular hemorrhage were observed in patients on anticoagulant therapy.
- All patients had a history of disciform macular degeneration.
- Hemorrhage originated from extrachoroidal neovascular vessels within the disciform lesions.
Findings:
- The extrachoroidal neovascularization led to rupture of the retinal pigment epithelium.
- Massive intraocular hemorrhage was the direct consequence of this rupture.
- Pre-existing disciform macular degeneration appeared to predispose patients to this complication.
Implications:
- Patients with exudative macular degeneration on anticoagulant therapy are at high risk for vision-threatening intraocular hemorrhage.
- Close collaboration between ophthalmologists and internists is crucial for managing these patients.
- Monitoring for and preventing intraocular bleeding is essential in this patient population.
Abstract:
The clinicopathologic correlation of three eyes with massive intraocular hemorrhage in patients receiving anticoagulant therapy is reported. All three patients were apparently predisposed because of antecedent disciform macular degeneration. The hemorrhage arose from the extrachoroidal neovascular vessels within the disciform lesions and caused rupture of the retinal pigment epithelium with massive intraocular hemorrhage. Because of the risk of vision-threatening intraocular hemorrhage, patients with exudative macular degeneration requiring anticoagulant therapy should be managed by both ophthalmologists and internists.